Log in

Biopharma Credit Share Forecast, Price & News

GBX 1.01
0.00 (0.00 %)
(As of 09/23/2020 12:00 AM ET)
Today's Range
Now: GBX 1.01
50-Day Range
MA: GBX 1.02
52-Week Range
Now: GBX 1.01
Volume487,937 shs
Average Volume1.20 million shs
Market Capitalization£13.88 million
P/E Ratio11.35
Dividend Yield6.90%
BioPharma Credit PLC, an investment trust, invests in interest-bearing debt assets secured by royalties or other cash flows derived from the royalties and sales of life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.06 out of 5 stars

Industry, Sector and Symbol

Industry Asset Management



Sales & Book Value

Annual Sales£150.90 million
Cash FlowGBX 21.49 per share
Book ValueGBX 102.20 per share



Outstanding Shares1,373,869,952
Market Cap£13.88 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 1.01
0.00 (0.00 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BPCR News and Ratings via Email

Sign-up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Biopharma Credit (LON:BPCR) Frequently Asked Questions

How has Biopharma Credit's stock been impacted by Coronavirus (COVID-19)?

Biopharma Credit's stock was trading at GBX 0.98 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BPCR shares have increased by 2.6% and is now trading at GBX 1.01.
View which stocks have been most impacted by COVID-19

How often does Biopharma Credit pay dividends? What is the dividend yield for Biopharma Credit?

Biopharma Credit announced a dividend on Wednesday, August 12th. Stockholders of record on Thursday, August 20th will be paid a dividend of GBX 0.02 per share on Friday, September 18th. This represents a yield of 1.7%. The ex-dividend date is Thursday, August 20th. The official announcement can be seen at this link.
View Biopharma Credit's dividend history

Who are some of Biopharma Credit's key competitors?

What other stocks do shareholders of Biopharma Credit own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biopharma Credit investors own include African Potash (AFPO), Altius Minerals (ATUSF), LiDCO Group (LID), Satellite Solutions Worldwide (SAT), San Juan Basin Royalty Trust (SJT), ANGLE (AGL), Hochschild Mining (HOC), SPX Flow (FLOW), Fulcrum Utility Services (FCRM) and DX (Group) (DX).

Who are Biopharma Credit's key executives?

Biopharma Credit's management team includes the following people:
  • Mr. Pedro Gonzalez de Cosio, Investment Mang.
  • Mr. Pablo G. Legorreta, Investment Mang.
  • Mr. Martin G. Friedman, Investment Mang. (Age 54)

What is Biopharma Credit's stock symbol?

Biopharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCR."

How do I buy shares of Biopharma Credit?

Shares of BPCR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Biopharma Credit's stock price today?

One share of BPCR stock can currently be purchased for approximately GBX 1.01.

How big of a company is Biopharma Credit?

Biopharma Credit has a market capitalization of £13.88 million and generates £150.90 million in revenue each year.

What is Biopharma Credit's official website?

The official website for Biopharma Credit is www.bpcruk.com.

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.